ArticleMolecular microbiology2026
A Phosphorylation-Dependent Partner-Switching-Like Module Regulates a Glycosyltransferase Required for Heterocyst Polysaccharide Layer Formation in Anabaena sp. Strain PCC 7120.
Article in Molecular microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Heterocyst-specific polysaccharide (Hep) is an essential component of the heterocyst envelope in the filamentous cyanobacterium Anabaena sp. PCC 7120; however, the regulatory mechanisms that control Hep layer formation remain poorly understood. Herein, we reveal that Hep layer formation is regulated by a phosphorylation-dependent partner-switching-like system involving the phosphatase HenR and the STAS domain-containing glycosyltransferase All4160. A nonphosphorylatable All4160 variant restores Hep formation in a henR disruptant, indicating that phosphorylation negatively regulates All4160 function. Using a bacterial two-hybrid assay, we identified two candidate kinases that interact with All4160, that is, Alr3423 and All2284, which phosphorylate All4160 in vitro. Genetic analysis revealed that deletion of alr3423, not all2284, suppresses the defect of the henR disruptant, indicating that Alr3423 plays a key role in regulating All4160 in vivo. This study identifies a phosphorylation switch that controls Hep layer formation and reveals a regulatory mechanism acting directly on a polysaccharide biosynthetic enzyme.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.